The a2 Milk Co Ltd (ASX: A2M) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
The a2 Milk Co Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Should you invest $1,000 in The A2 Milk Company Limited right now?
Before you buy The A2 Milk Company Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 6 March 2025
The a2 Milk Co Ltd (ASX: A2M)
Latest News

Broker Notes
Why A2 Milk shares and this mid cap ASX share could be buys

Share Market News
ASX 200 rebounds as investors seek bargains following market sell-off

Share Market News
5 things to watch on the ASX 200 on Thursday

How to invest
How you could profit from Trump's tariffs

Share Gainers
Here are the top 10 ASX 200 shares today

Dividend Investing
21 ASX shares going ex-dividend next week

Share Gainers
4 ASX All Ords stocks shrugging off the looming 2025 market correction and charging higher

Cheap Shares
Leading fund manager bullish on these 2 exciting ASX 200 shares

Consumer Staples & Discretionary Shares
A2 Milk shares rocketed 35% in February: Are there more gains ahead?

Share Gainers
These were the best-performing ASX 200 shares in February 2025

52-Week Highs
These 4 ASX 200 shares just clocked new 52-week highs today

52-Week Highs
8 ASX 300 shares hitting new price highs today
Frequently Asked Questions
-
The a2 Milk Company Ltd does not currently pay a dividend.
-
The a2 Milk Company Ltd does not currently have a dividend reinvestment program.
-
The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
20 Mar 2025 | $0.0650 | 0.00% | Interim | 04 Apr 2025 |
A2M ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|
About The a2 Milk Co Ltd
A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.
The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.
The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.
A2M Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
25 Mar 2025 | $8.02 | $-0.03 | -0.37% | 2,038,965 | $8.00 | $8.09 | $7.88 |
24 Mar 2025 | $8.05 | $-0.08 | -0.98% | 2,549,763 | $8.10 | $8.17 | $7.97 |
21 Mar 2025 | $8.13 | $-0.23 | -2.75% | 9,975,799 | $8.32 | $8.35 | $8.11 |
20 Mar 2025 | $8.36 | $0.04 | 0.48% | 4,684,866 | $8.24 | $8.41 | $8.23 |
19 Mar 2025 | $8.32 | $-0.21 | -2.46% | 7,322,790 | $8.69 | $8.87 | $8.30 |
18 Mar 2025 | $8.53 | $-0.32 | -3.62% | 2,684,636 | $8.90 | $8.93 | $8.52 |
17 Mar 2025 | $8.85 | $0.20 | 2.31% | 6,380,997 | $8.70 | $9.08 | $8.70 |
14 Mar 2025 | $8.65 | $0.70 | 8.81% | 6,748,684 | $8.00 | $8.65 | $7.98 |
13 Mar 2025 | $7.95 | $0.01 | 0.13% | 5,902,825 | $7.92 | $8.12 | $7.90 |
12 Mar 2025 | $7.94 | $-0.03 | -0.38% | 2,961,056 | $7.96 | $8.06 | $7.92 |
11 Mar 2025 | $7.97 | $-0.05 | -0.62% | 3,485,311 | $8.00 | $8.18 | $7.97 |
10 Mar 2025 | $8.02 | $-0.03 | -0.37% | 2,924,640 | $8.05 | $8.18 | $8.01 |
07 Mar 2025 | $8.05 | $-0.02 | -0.25% | 1,628,507 | $8.05 | $8.15 | $8.03 |
06 Mar 2025 | $8.07 | $0.09 | 1.13% | 1,934,839 | $7.97 | $8.12 | $7.95 |
05 Mar 2025 | $7.98 | $0.01 | 0.13% | 3,698,977 | $7.90 | $8.04 | $7.80 |
04 Mar 2025 | $7.97 | $-0.09 | -1.12% | 1,984,492 | $7.95 | $8.04 | $7.86 |
03 Mar 2025 | $8.06 | $0.08 | 1.00% | 2,566,832 | $7.98 | $8.06 | $7.92 |
28 Feb 2025 | $7.98 | $-0.12 | -1.48% | 3,387,088 | $8.08 | $8.17 | $7.91 |
27 Feb 2025 | $8.10 | $0.15 | 1.89% | 2,890,541 | $7.95 | $8.20 | $7.92 |
26 Feb 2025 | $7.95 | $0.03 | 0.38% | 3,561,770 | $7.86 | $8.03 | $7.85 |
25 Feb 2025 | $7.92 | $0.20 | 2.59% | 3,341,406 | $7.60 | $7.92 | $7.59 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
09 Dec 2024 | David Bortolussi | Issued | 538,336 | $3,063,131 |
Issue of securities. 1,729,582 performance rights
|
30 Aug 2024 | David Bortolussi | Buy | 490,906 | $2,744,164 |
Conversion of securities.
|
30 Aug 2024 | David Bortolussi | Exercise | 490,906 | $2,744,164 |
Conversion of securities. 1,191,246 performance rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr David Landt Bortolussi | Chief Executive OfficerManaging Director | Feb 2021 |
Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
|
Ms Philippa (Pip) Mary Greenwood | Non-Executive ChairmanNon-Executive Director | Jul 2019 |
Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
|
Ms Kathryn(Kate) Mitchell | Non-Executive Director | Jun 2023 |
Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
|
Ms Sandra Yu | Non-Executive Director | Mar 2022 |
Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
|
Mr Antonio (Tonet) Rivera | Non-Executive Director | Nov 2024 |
Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Mr Rivera worked for Mead Johnson Nutrition from 2002 to 2017, in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Mr Rivera has worked as a supply chain consultant.
|
Mr Lain Jager | Non-Executive Director | Dec 2024 |
Mr Jager brings international, agribusiness leadership experience to the Board through his former role as CEO of Zespri International. Since stepping down from Zespri in 2017, Lain has on private business interests including personal investments in a range of entrepreneurial, technology and agriculture related businesses. Mr Jager is based in New Zealand. The Board has determined that Mr Jager will be an independent director. He will also be a member of the Boards People and Remuneration Committee.
|
Mr Jaron McVicar | Company SecretaryGeneral Counsel | Nov 2016 |
-
|
Jaron McVicar | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 113,290,528 | 15.67% |
Citicorp Nominees Pty Limited | 96,163,814 | 13.30% |
BNP Paribas Nominees NZ Limited Bpss40* | 42,529,528 | 5.88% |
J P Morgan Nominees Australia Pty Limited | 34,661,044 | 4.79% |
HSBC Nominees (New Zealand) Limited* | 26,156,306 | 3.62% |
Tea Custodians Limited* | 21,013,734 | 2.91% |
HSBC Custody Nominees (Australia) Limited Gsco Eca | 20,980,543 | 2.90% |
Accident Compensation Corporation* | 20,509,205 | 2.84% |
JPMORGAN Chase Bank* | 18,595,095 | 2.57% |
New Zealand Superannuation Fund Nominees Limited* | 17,659,815 | 2.44% |
Citibank Nominees (NZ) Ltd* | 15,787,511 | 2.18% |
New Zealand Depository Nominee | 14,021,429 | 1.94% |
National Nominees Limited | 13,425,469 | 1.86% |
HSBC Nominees (New Zealand) Limited* i | 9,463,432 | 1.31% |
Premier Nominees Limited* | 8,473,699 | 1.17% |
Public Trust* | 7,323,398 | 1.01% |
UBS Nominees Pty Ltd | 6,938,917 | 0.96% |
New Zealand Permanent Trustees Limited* | 6,325,699 | 0.88% |
BNP Paribas Noms Pty Ltd | 6,123,304 | 0.85% |
JBWere (NZ) Nominees Limited | 5,945,531 | 0.82% |